Microcytosis in agnogenic myeloid metaplasia: prevalence and clinical correlates

Leuk Res. 2006 Jun;30(6):677-80. doi: 10.1016/j.leukres.2005.10.006. Epub 2005 Nov 8.

Abstract

Microcytosis is a characteristic laboratory feature for both iron deficiency anemia and thalassemia. It is also infrequently seen in "anemia of chronic disease" that accompanies a spectrum of chronic conditions including rheumatoid arthritis, polymyalgia rheumatica, diabetes mellitus, connective tissue disease, and protracted infection. In addition, there is a well established but pathogenetically obscure association of microcytosis with Hodgkin's lymphoma, Castleman's disease, and renal cell carcinoma. In the current study, we show that microcytosis is a frequent laboratory feature in agnogenic myeloid metaplasia and investigate its clinical relevance in the particular setting.

MeSH terms

  • Adolescent
  • Adult
  • Anemia, Iron-Deficiency / complications
  • Anemia, Iron-Deficiency / mortality
  • Anemia, Iron-Deficiency / pathology
  • Anemia, Macrocytic / complications
  • Anemia, Macrocytic / mortality*
  • Anemia, Macrocytic / pathology
  • Carcinoma, Renal Cell / complications
  • Carcinoma, Renal Cell / mortality
  • Carcinoma, Renal Cell / pathology
  • Castleman Disease / complications
  • Castleman Disease / mortality
  • Castleman Disease / pathology
  • Female
  • Hodgkin Disease / complications
  • Hodgkin Disease / mortality
  • Hodgkin Disease / pathology
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Primary Myelofibrosis / complications
  • Primary Myelofibrosis / mortality*
  • Primary Myelofibrosis / pathology
  • Thalassemia / complications
  • Thalassemia / mortality
  • Thalassemia / pathology